secwatch.observer — SEC 8-K summary
======================================

Issuer:     DBV Technologies S.A. (DBVT)
CIK:        0001613780
Form:       8-K
Filed at:   2025-01-08T23:59:59+00:00
Accession:  0001193125-25-003574
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DBV Technologies reports positive 3-year EPITOPE OLE data; 68.2% passed food challenge at month 36
--------------------------------------------------------------------------------

- 68.2% of toddlers completed oral food challenge (~12-14 peanut kernels) without meeting stopping criteria at month 36, vs 30.7% at month 12.
- 83.5% reached eliciting dose ≥1000 mg after three years on Viaskin Peanut, up from 64.2% at month 12.
- No treatment-related anaphylaxis or serious TEAEs occurred in year 3; local application-site reactions decreased vs earlier years.
- New wear-time analysis: subjects with average daily wear time ≥20 hours (68.4% of active group) showed 75.7% responder rate vs 47.3% for <20 hours.
- Data presented at Eastern Food Allergy & Comorbidity Conference; investor webcast on Jan 8, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1613780/000119312525003574/0001193125-25-003574-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1613780/000119312525003574/d861550d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-003574

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer